Galvanize

QV Bioelectronics

The company develops implantable bioelectronic devices that deliver electric field therapy to treat patients with aggressive brain tumours.

Ablatus Therapeutics

This company develops a bimodal electric tissue ablation medical device to treat tumours and uterine fibroids for surgical patients.

Endogenex

This company develops an endoscopic system using pulsed electric fields to treat type 2 diabetes by regenerating signalling cells in the small intestine.

HEPTA Medical

This company develops a microwave ablation platform with integrated temperature sensors for clinicians to treat early-stage lung cancer patients using minimally invasive procedures.

Maxwellbiomedical

This company develops an electrical stimulation platform for patients with atrial fibrillation to restore heart rhythms and function without destroying tissue.

Alpfa Medical

The company develops pulsed field ablation systems to treat benign prostatic hyperplasia in men.

Neuromodulation

This company develops miniaturised peripheral nerve stimulation implants and wireless power systems to treat patients suffering from chronic neuropathic pain.

TwoStep Therapeutics

The company develops peptide-drug conjugates and targeted therapies for patients with solid tumours.